Validating an S/4 HANA ERP Upgrade for Medical Device Compliance

REPHINE SPEECH MARKS OPEN DIGITALISATION

Rephine’s expertise and support were
invaluable in ensuring our S/4 HANA system
upgrade was compliant with medical device
industry regulations. Their clear communication and
collaborative approach made a significant difference
in the success of this project. We’re confident that
the system improvements will continue to support
our commitment to quality and traceability in the
medical device distribution process.

REPHINE SPEECH MARKS CLOSE DIGITALISATION

About this Case Study

In this case study, we explore how Rephine supported PALEX, a leading European medical device distributor, in validating its upgraded S/4 HANA ERP system to meet strict regulatory requirements.

With core business processes such as purchasing, sales, and inventory management migrating to the new system, PALEX needed to ensure full compliance with EU medical device regulations—particularly around traceability, quality management, and risk control.

Rephine’s consultants delivered a comprehensive validation approach that enabled PALEX to:

  • Ensure the S/4 HANA upgrade met applicable regulatory standards
  • Optimise validation processes and reduce manual intervention risks
  • Strengthen oversight of key operational workflows
  • Improve cross-functional alignment through training and communication
  • Stay on schedule through proactive project management

Over the course of the project, Rephine helped PALEX move from risk exposure to full system validation—supporting not only compliance but improved operational consistency and digital readiness.

Download the full case study now to see how we turned ERP complexity into a validated, regulator-ready system.

 

Download the Case Study

View other our other resources and company news

GMP Raising the bar Blog series Header image May 25 Blog

EMA vs USFDA: AI Compliance in GxP Pharma Environments

With AI reshaping pharma, global firms must align with both EMA and USFDA guidance. This article unpacks the regulatory differences and offers practical tips for ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

EMA Draft Revisions to EU GMP: Annex 11, Annex 22 & AI

The EMA has launched public consultation on major EU GMP updates, including new requirements for AI, documentation, and computerised systems. Here’s what pharma and biotech ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

Understanding ALCOA+ and Data Integrity in GxP Compliance

Data integrity is central to regulatory compliance in pharma and biotech. Discover how ALCOA and ALCOA+ principles help organisations uphold GxP standards—and how Rephine supports ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

GxP Compliance in Emerging Markets

Emerging markets face unique regulatory challenges in maintaining pharmaceutical quality and safety. Learn how GxP compliance, third-party GMP audits, and digital tools from Rephine support ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

Sustainable Auditing in Pharma: Eco-Friendly GxP & GMP Compliance

As ESG targets grow more critical, pharma firms are rethinking audit models. Explore how sustainable auditing helps cut emissions while ensuring compliance.
Read More
GMP Raising the bar Blog series Header image May 25 Blog

Building Resilient Pharmaceutical Supplier Ecosystems

In today's volatile landscape, traditional supplier qualification is no longer enough. Learn how pharma companies can build resilient supplier ecosystems through risk-based strategies, real-time monitoring, ...
Read More
CPV Header image blog apr 25 Blog

IT Quality Assurance in Pharma: Ensuring Compliance, Validation & Data Integrity

IT Quality Assurance plays a pivotal role in the life sciences sector, ensuring systems are validated, compliant, and audit-ready. Learn how pharma companies can meet ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

IT Quality Assurance in Pharma: Ensuring Compliance, Validation & Data Integrity

Artificial intelligence and data analytics are reshaping pharmaceutical GMP compliance—but not all innovations are audit-ready. This article explores proven AI use cases, regulator expectations, and ...
Read More
GMP Raising the bar Blog series Header image May 25 Blog

Risk-Based Auditing: Smarter GxP Compliance with Limited Resources

In today’s pharma landscape, risk-based auditing enables smarter supplier oversight by aligning audit efforts with risk. Discover the benefits, regulatory backing, and how Rephine helps ...
Read More
Contact Us